References
- Omaye ST. Metabolic modulation of carbon monoxide toxicity. Toxicology 2002;180:139-50. https://doi.org/10.1016/S0300-483X(02)00387-6
- Hampson NB, Hauff NM. Risk factors for short-term mortality from carbon monoxide poisoning treated with hyperbaric oxygen. Crit Care Med 2008;36:2523-7. https://doi.org/10.1097/CCM.0b013e31818419d8
- Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005;45:1513-6. https://doi.org/10.1016/j.jacc.2005.01.044
- Kao LW, Nanagas KA.Carbon monoxide poisoning. Emerg Med Clin North Am 2004;22:985-1018. https://doi.org/10.1016/j.emc.2004.05.003
- Gandini C, Castoldi AF, Candura SM, et al. Carbon monoxide cardiotoxicity. J Toxicol Clin Toxicol 2001;39:35-44. https://doi.org/10.1081/CLT-100102878
- Jang WI, Park JH. Transient left ventricular systolic dysfunction associated with carbon monoxide toxicity. J Cardiovasc Ultrasound 2010;18:12-5. https://doi.org/10.4250/jcu.2010.18.1.12
- Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 2006;295:398-402. https://doi.org/10.1001/jama.295.4.398
- Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. https://doi.org/10.1016/j.echo.2005.10.005
- Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143: 29-36. https://doi.org/10.1148/radiology.143.1.7063747
- McMeekin JD, Finegan BA. Reversible myocardial dysfunction following carbon monoxide poisoning. Can J Cardiol 1987;3:118-21.
- Anderson RF, Allensworth DC, DeGroot WJ. Myocardial toxicity from carbon monoxide poisoning. Ann Intern Med 1967;67:1172-82. https://doi.org/10.7326/0003-4819-67-6-1172
- Marius-Nunez AL. Myocardial infarction with normal coronary arteries after acute exposure to carbon monoxide. Chest 1990;97: 491-4. https://doi.org/10.1378/chest.97.2.491
- Ahn KT, Park JH, Kim MS, et al. Prevalence and clinical outcomes of left ventricular systolic dysfunction after carbon monoxide exposure. Int J Cardiol 2011;153:108-10. https://doi.org/10.1016/j.ijcard.2011.09.024
- Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989;321:1426-32. https://doi.org/10.1056/NEJM198911233212102
- Kalay N, Ozdogru I, Cetinkaya Y, et al. Cardiovascular effects of carbon monoxide poisoning. Am J Cardiol 2007;99:322-4. https://doi.org/10.1016/j.amjcard.2006.08.030
- Cha YS, Cha KC, Kim OH, Lee KH, Hwang SO, Kim H. Features and predictors of myocardial injury in carbon monoxide poisoned patients. Emerg Med J 2014;31:210-5. https://doi.org/10.1136/emermed-2012-202152
- Thompson N, Henry JA. Carbon monoxide poisoning: poisons unit experience over five years. Human Toxicol 1983;2:335-8. https://doi.org/10.1177/096032718300200226
- Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning--a public health perspective. Toxicology 2000;145:1-14. https://doi.org/10.1016/S0300-483X(99)00217-6
- Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. https://doi.org/10.1056/NEJMoa020233
- Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54. https://doi.org/10.1056/NEJMoa031681
- Mark DB, Felker GM. B-type natriuretic peptide - a biomarker for all seasons? N Engl J Med 2004;350:718-20. https://doi.org/10.1056/NEJMe038233
- Davutoglu V, Gunay N, Kocoglu H, et al. Serum levels of NT-ProBNP as an early cardiac marker of carbon monoxide poisoning. Inhal Toxicol 2006;18:155-8. https://doi.org/10.1080/08958370500305885
Cited by
- Predicting Cardiotoxic Effects of Carbon Monoxide Poisoning Using Speckle Tracking Echocardiography vol.18, pp.2, 2016, https://doi.org/10.1007/s12012-017-9428-9
- Role of ECMO in life threatening intoxication vol.6, pp.3, 2018, https://doi.org/10.1016/j.ejccm.2018.12.007
- Evaluation of the Cardioprotective Effect of Granulocyte Colony Stimulating Factor in Patients with Carbon Monoxide Poisoning vol.27, pp.None, 2016, https://doi.org/10.2174/0929866527666201022112810
- Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning vol.30, pp.8, 2016, https://doi.org/10.1017/s1047951120001651